SMTL ID : 6cmr.1

Closed structure of active SHP2 mutant E76D bound to SHP099 inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.21 Å

Oligo State

monomer

Ligands

1 x 5OD: 6-(4-azanyl-4-methyl-piperidin-1-yl)-3-[2,3-bis(chloranyl)phenyl]pyrazin-2-amine(Non-covalent)

5OD.1: 18 residues within 4Å: Chain A: T.111, S.112, E.113, R.114, F.116, H.117, N.220, T.221, T.222, E.252, E.253, T.256, L.257, Q.260, D.492, P.494, K.495, Q.498 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:P.494, A:P.494, A:K.495 Hydrogen bonds: A:R.114, A:E.252, A:E.253 pi-Cation interactions: A:R.114 Halogen bonds: A:T.256

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Padua, R.A.P. et al., Mechanism of activating mutations and allosteric drug inhibition of the phosphatase SHP2. Nat Commun (2018)

Release Date

2018-11-14

Peptides

Tyrosine-protein phosphatase non-receptor type 11: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein phosphatase non-receptor type 11